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AbstrAct
Objectives: Henoch-Schönlein purpura (HSP) or IgA vasculitis, 
is the most common form of childhood vasculitis. Mean platelet 
volume (MPV) is a parameter of a complete blood count that shows 
thrombocyte function and activation. This study evaluated the link 
between MPV and HSP.
Patients and Methods: The data of 75 patients with a 
diagnosis of HSP were retrospectively evaluated. A control group 
was formed with 79 healthy children of similar gender and ages. 
results: The average ages were 6.8±3.02 years (44 males, 31 
females) and 7.49±2.95 years (40 males, 39 females) for the patient 
and control groups respectively. Mean platelet volume was found 
to be significantly lower in the study group (p<0.0001). Patients’ 
thrombocyte count were significantly higher (p<0.0001). Upon 
presentation 18 patients’ faecal occult blood  (FOB) test results 
were positive, and there was microscopic hematuria in 12 patients, 
MPV was found to be significantly lower in FOB positive patients 
(p=0.043).
conclusion: Inflammation may affect MPV levels by 
increasing or decreasing. In our study, MPV measurements 
performed by a cheap and simple method, have been considered 
as a negative acute phase reactant. Decreased MPV measurements 
despite increased platelet count may be important in the prediction 
of hypercoagulopathy problems during the likely course of the 
disease and in close follow up for those with a predisposition. 
Keywords: Henoch-Schönlein Purpura, Ig-A Vasculitis, Mean 
platelet volume, Platelet count, Hematuria, Fecal occult blood
ÖZEt 
Amaç: Henoch-Schönlein purpurası (HSP) ya da IgA vasküliti, 
çocukluk çağında en sık görülen vaskülittir. Tam kan sayımındaki 
parametrelerden biri olan ortalama trombosit hacmi (OTH), 
trombosit aktivasyonu ve fonksiyonunu gösteren bir belirteçtir. 
Çalışmamızda HSP ile OTH arasındaki ilişkinin araştırılması 
amaçlanmıştır. 
Hastalar ve Yöntemler:  Kliniğimizde HSP tanılı 75 hastanın 
verileri retrospektif olarak değerlendirildi. Cinsiyet ve yaşları 
benzer 79 sağlıklı çocuk ile kontrol grubu oluşturuldu. 
bulgular: Yaş ortalaması hastalarda 6,8±3,02 yıl (44 erkek, 
31 kız), kontrol grubunda7,49±2,95 yıl (40 erkek, 39 kız) idi. 
Ortalama trombosit hacmi çalışma grubunda anlamlı derecede 
düşük saptandı (p<0,0001). Hastaların trombosit sayısı anlamlı 
derecede yüksek bulundu (p<0,0001). Başvuru anında 18 hastada 
gizli gaite kan (GGK) testi pozitifti ve 12 hastada mikroskopik 
hematüri mevcuttu, GGK pozitif olan hastalarda OTH anlamlı 
düşük bulundu (p=0,043).
sonuç: İnflamasyon, OTH düzeyini artma/azalma şeklinde 
etkileyebilmektedir. Çalışmamızda ucuz ve basit bir yöntem olan 
OTH ölçümleri  negatif akut faz reaktanı olarak değerlendirilmiştir. 
Henoch-Schönlein purpuralı çocuklarda, artmış trombosit sayısına 
karşın, azalmış OTH ölçümlerinin, yatkınlığı olanlarda, hastalık 
seyrindeki olası hiperkoagülopati problemlerinin önceden 
belirlenmesinde ve yakın takipte önemli olabileceği kanısına 
varılmıştır.
Anahtar kelimeler: Henoch-Schönlein purpurası, IgA vasküliti, 
Ortalama trombosit hacmi, Trombosit sayısı, Hematüri, Gaitada 
gizli kan
Introduction
Henoch-Schönlein purpura (HSP) was first defined in 1801 
by Heberden in a child of five years with stomach pain, 
vomiting, melena, arthralgia, haematuria and purpuric rash. 
Later Schönlein attested that arthralgia and purpuric skin rash 
accompanied each other and called this peliosis rheumatic 
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[1,2]. It is reported to have an annual incidence of between 
14-20/100.000 [2,3], while this is higher in males [2-4] 
(male/female ratio 1.4-1.8). Clinical findings are significant 
in diagnosis, skin or kidney biopsy is often not necessary. 
Diagnostic criteria of HSP, together with other childhood 
vasculitis were presented by Özen et al in 2006, and the 
final edited version was published in 2010 under the name 
of 2008 Ankara final classification criteria  (Table I) [5,6], 
Henoch-Schönlein purpura, was renamed as IgA vasculitis 
with the “International Chapel Hill Consensus Conference 
on the Nomenclature of Vasculitides” statement in 2012. 
In the course of the disease, palpable purpura mostly over 
the lower extremities with the skin, stomach pain, bleeding, 
invagination in the gastrointestinal system, arthritis or 
arthralgia in the joints and in renal involvement hematuria 
or varying degrees of proteinuria may occur. Less often, 
signs and symptoms may be seen in many other systems 
[2,3]. While HSP, progresses without complications in mild 
cases, in severe cases complications in the gastrointerstinal 
system in acute phase, and renal complications in chronic 
phase determine the prognosis [2]. While some publications 
have reported that the determination of nephrotic range 
proteinuria during first presentation or the deterioration of 
kidney function is a risk factor for renal failure within 20 
years following diagnosis [2-8], in an Italian cohort study, 
the authors showed that early symptoms are not significant 
in determining the prognosis [2,9,10]. 
Platelet volume has been identified as a marker of platelet 
activation and function and mean platelet volume (MPV) 
is one of the routine parameters in complete blood count 
test. Diseases such as myocardial infarction, pulmonary 
embolism, acute pancreatitis, familial mediterranean fever, 
diabetic retinopathy and chronic obstructive pulmonary 
disease associated with inflammation, hypoxia, vascular 
injury, thrombosis and atherosclerosis were found to be 
associated with MPV [11-15]. Our study aimed to investigate 
the relationship between HSP and MPV.
table I. Final EULAR/PRINTO/PRES HSP criteria (with glossary) and classification definition (sample 973) [6]
Patients and Methods
In this study, the data of patients presenting between January 
2008-December 2013 to the pediatric nephrology clinic and 
pediatric emergency unit with HSP diagnosis was reviewed 
retrospectively. Our study was approved by our Hospital 
Clinical Research Ethics Committee on 15.09.2014 with 
the decision numbered 2014/12/10. Patients with missing 
information were excluded from the study. Seventy-five 
patients were included in the study. Patient presentation, 
age, gender, platelet count (in cubic millimetre), MPV (fL), 
plateletcrit (PCT), urinalysis, positive fecal occult blood 
(FOB), liver and kidney function test results were recorded 
from patient files. Calculation of the number of platelets were 
over /1000 value (PLT/1000). To create the control group, 79 
healthy children were included in the study. In the automatic 
complete blood count, EDTA containing tubes were used 
and studied within one hour, and data obtained from LH 750, 
Beckman Coulter, England system was evaluated.
Statistical analysis was performed with SPSS 20 
program. In the evaluation of quantitative data, in addition 
to descriptive statistical methods (mean, standard deviation), 
depending on distribution property in comparison between 
groups Student’s-t or Mann-Whitney-U tests, and in the 
comparison of qualitative data chi-square and Fisher’s 
exact tests were used. As a final consequence, p< 0.05 was 
considered for statistically significant values.
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results
The mean age of 44 male and 31 female children assessed 
within the HSP group was 6.8±3.02 years. Of the children 
in the control group, 40 were male and 39 female, and the 
mean age was found to be 7.49±2.95 years. There was no 
statistically significant difference between age and gender 
distribution between the groups (p=0.154, p=0.073). 
In the study and control groups, MPV was found to be 
7.28±0.73 fL; 8.42±0.67 fL respectively, MPV was found 
to be significantly lower in the study group (p=0,0001). 
The PLT/1000 average of the study group was found to 
be statistically significantly higher than the control group 
(p=0.0001) (Table II). Of the patients with HSP, 18 were 
FOB positive upon presentation, and microscopic hematuria 
was found in 12 patients. Other clinical manifestations of 
the patients are shown in Table III. While MPV average was 
6.97±0.48 fL in patients with positive FOB, it was found to 
be 7.36±0.76 fL in those with negative FOB. The difference 
was statistically significant (p=0.043) (Table IV). The mean 
age of patients with hematuria was 9.4 ± 2.86 years and 
6.3 ± 2.8 years in those without. There was a statistically 
significant difference between them (p = 0.0001) (Table V). 
No significant difference was determined between those with 
and without hematuria in terms of MPV, PCT and PLT/1000 
averages. In three of our patients invagination, and one acute 
appendicitis developed. Sixteen patients were admitted to 
hospital for treatment. There was no statistical difference 
between the age, MPV, PLT/1000 and PCT averages of the 
patients admitted and those treated as outpatients. When 
considering gender, it was determined that while 70.5% of 
male patients were admitted to hospital, 90.3% of female 
patients were admitted. The difference was statistically 
significant (p <0.05) (Table VI).
Renal biopsy was carried out on two patients due to 
persistent massive proteinuria during outpatient follow ups. 
The histopathological examination results were interpreted 
as mesengio-proliferative glomerulonephritis in one patient, 
and IgA cumulative minimal glomerular lesions in the other 
patient. Glomerular crescent formation was not observed in 
either patient. 
table II. Comparison of the data of the patient group and control 
group
control Group
n= 79
Patient Group
n= 75
p
Age (years) 7.49±2.95 6.8±3.02 0.154
Gender
n (%)
Male 44 57.89 40 50.63
0.073
Female 32 42.11 39 49.37
MPV (fL) 8.42±0.67 7.28±0.73 0.0001
Pct (%) 0.26±0.04 0.27±0.06 0.360
PLt/1000 (/mm3) 314.09±60.59 371.93±82.91 0.0001
MPV: mean platelet volume; PCT: plateletcrit; PLT: platelet count
table III.  Clinical and laboratory findings of patients
Findings Patients 
with 
findings
Patients 
without 
findings
ratio (%)
skin rash 74  0 100
Abdominal pain 39 36   52
Arthritis 16 59       21.3
soft tissue oedema 38 37       50.7
Proteinuria   3 72     4
Hematuria 12 63   16
Fecal occult blood 18 56      24.3
table IV. A comparison of patients with and without fecal occult 
blood positive
FOb positive 
patients
n=18
FOb negative 
patients
n=56
p
Age (years) 6.39±2.75 6.81±3.0 0.6
MPV (fL) 6.97±0.48 7.36±0.76 0.043
Pct (%) 0.26±0.05 0.27±0.06 0.76
PLt/1000 (/mm3) 382.94±71.79 369.46±86.86 0.55
FOB: fecal occult blood, MPV: mean platelet volume; PCT: plateletcrit; 
PLT: platelet count
table V. Comparison of patients with and without hematuria
Patients with 
microscopic 
hematuria
n=12
Patients without 
microscopic 
hematuria
n=63
p
Age (years) 9.4±2.86 6.3±2.8 0.001
MPV (fL) 7.27±0.68 7.28±0.75 0.923
Pct (%) 0.25±0.06 0.27±0.06 0.237
PLt/1000 (/mm3) 347.83±92.6 376.52±80.93 0.275
MPV: mean platelet volume; PCT: plateletcrit; PLT: platelet count
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table VI.  Comparison of patient data for those admitted to 
hospital and those with outpatient follow up
those 
admitted to 
hospital
n=59
No hospital 
admissions
n=16
p
Age (years) 7.13±2.97 5.59±2.97 0.066
Gender
n (%) 
Male 31 (70.5) 13 (29.5)
0.048
Female 28 (90.3) 3 (21.3)
MPV (fL) 7.24±0.71 7.43±0.82 0.592
Pct (%) 0.27±0.06 0.26±0.64 0.732
PLt/1000
(/mm3) 
375.66±80.18 358.19±93.8 0.233
Discussion
While HSP was defined at the beginning of the 19th century, 
its exact etiology remains unclear. It is much more common 
in children than in adults. It is reported that it generally 
occurs between the ages of 5-15, on average around 5-6 
years of age [4,16-19]. As palpable purpuric rash of different 
sizes from small petechiae to large ecchymoses which are 
more dominant on the lower extremities is characteristic in 
HSP, it is generally diagnostic. Gastrointestinal involvement 
is the third most commonly affected area after the skin and 
joint involvement. It occurs in approximately two-thirds of 
children. In a multicenter study conducted in our country 
by Peru et al, FOB involvement in children with HSP 
was found in 50% of patients, and renal involvement was 
found in 30% of patients [20]. Oedema and bleeding due 
to vasculitis developing on the intestinal wall; may lead 
to invagination, gangrene or perforation [3,4,21]. Surgical 
complications are rare in adults and children under the age 
of three. The most common surgical complication in patients 
with gastrointestinal involvement is invagination, and its 
incidence is known to be less than 1% [3,4,22-24]. In our 
study, three patients have been operated due to invagination 
(0.04%). Henoch-Schönlein purpura nephritis is usually 
seen as spontaneously resolving microscopic hematuria and 
/ or mild proteinuria. If there are initial findings of massive 
proteinuria and nephrotic or nephritic syndrome symptoms, 
it may progress rapidly. Publications report 15-62% renal 
involvement with HSP in the early period, and between 
1-2% in the long term, however late stage renal failure 
incidence is between 0-3% [3,25-27]. In our patient group, 
hematuria was detected in 12 patients, and proteinuria was 
detected in three patients. In two of these both hematuria 
and proteinuria, and in one isolated proteinuria was present. 
Renal involvement in a total of 13 patients was found to 
be 17.3% of total patients. The detection of longstanding 
proteinuria in two patients (2.6%) was consistent with 
literature. Platelets, hemostasis and endothelial repair 
has a vital role, and also plays a significant role in the 
development of atherothrombosis [28]. Platelet volume is an 
indicator of platelet function and activation [29]. It has been 
reported that platelet count increases and MPV decreases in 
many inflammatory diseases [30,31]. In contract, in many 
prothrombotic disorders, MPV was determined to be high 
[32].
While there are studies showing that MPV is higher 
in rheumatoid arthritis, there are also studies showing 
that it is lower [33,34]. Gasparyan has reported that MPV 
average is higher in patients with hypertension together 
with rheumatoid arthritis [33]. In a study by Kısacık et al, in 
patients with active ankylosing spondylitis and rheumatoid 
arthritis, platelet volume has been found to be lower and with 
treatment an increase in MPV levels and normalizing has 
been seen [34]. Uysal et al., have reported that MPV is lower 
in cystic fibrosis patients during acute attack in comparison 
with those not in attack, and in those outside of acute attack, a 
lower MPV has been determined in comparison with healthy 
patients [35]. In many other studies, MPV has been found 
to be low during active disease in adult ulcerative colitis 
patients, while platelet number has found to be high [30-32]. 
MPV levels have been reported to be significantly lower in 
patients with gastrointestinal bleeding in a study by Makay 
et al[36]. In a majority of prothrombotic diseases, MPV 
has been found to be high and to be associated with disease 
activity [32]. MPV value prior to percutaneous coronary 
angiography in acute coronary syndrome has been found to 
be a similar indicator of prognosis as troponin [37]. It has 
been reported that MPV increases in chronic renal patients 
proportionally to the decrease in estimated glomerular 
filtration rate (eGFR), and that MPV is higher in patients 
with coronary artery disease than those without [38]. There 
are publications available showing that thrombotic events are 
more frequent in vasculitis [39,40]. MPV has been reported 
to be high in Behçet’s disease patients with thrombosis [41].
In our study, MPV levels were found to be significantly 
lower in patients with HSP in comparison with the control 
group, while platelet counts were found to be significantly 
higher. No difference was determined between the groups 
in terms of PCT value impacted in the opposite direction by 
these two parameters.
The increase in platelet count in order to balance the 
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decrease in platelet activity as a result of the decrease of MPV 
levels may be a measure taken by the organism for the proper 
operation of the hemostasis system. In HSP patients, MPV 
levels were also found to be decreased in gastrointestinal 
system involvement. In contrast, the increase in platelet 
count determined in patients in comparison with the control 
group was not observed in patients with GI bleeding. The 
decreased MPV and increased platelet count in patients with 
gastrointestinal bleeding suggests that a reduction in platelet 
activity may have been caused.
Henoch Schönlein purpura, generally has a much 
better prognosis than most other vasculitis and most 
patients recover uneventfully [3,42]. When considering the 
relationship between increased platelet activity and vascular 
damage, the prognosis being better with this disease may be 
related to the vascular damage induced by platelets being 
less severe. In our study, the MPV average of HSP patients 
was found to be significantly lower in comparison with 
healthy controls. MPV being found to be higher in the course 
of other vasculitis and diseases with thrombosis supports 
the contribution of platelet activation in the formation of 
vascular complications. Due to the low number of patients 
in our study, the relationship between renal involvement and 
MPV was not evaluated, and broader studies are required in 
this regard.
In conclusion our study showed that MPV may be a 
guide in the disease activity in the follow up of patients with 
HSP. Care must be taken in terms of vascular complications 
in patients whose MPV decrease could not be determined 
as expected in normal course. There is a need for further 
studies with larger number of patients with long term follow 
up.
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